RecruitingNot ApplicableNCT03735992

Mind-body Medicine for Patients With Malignant Hematological Diseases

Mind-body Medicine as a Supportive Strategy for Patients With Malignant Hematological Diseases: a Randomized Controlled Trial


Sponsor

Universität Duisburg-Essen

Enrollment

94 participants

Start Date

Sep 6, 2017

Study Type

INTERVENTIONAL

Conditions

Summary

This randomized controlled trial aims to investigate the effectiveness of a mind-body group program as a supprtivemanagement strategy for fatigue in patients with malignant hematological diseases.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Patients with malignant hematological diseases in complete remission after primary chemotherapy and/or radiation
  • Physical and mental ability to attent 8 of 11 group units

Exclusion Criteria3

  • Chemotherapy, radiation, or rehabilitation programm during the study period
  • Pregnancy
  • Participation in other studies with behavioral interventions during the study period

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALMind-body medicine group program

The group program is mainly based on MBSR. It further integrates elements of the mind-body medicine cancer program of the Benson-Henry Mind/Body Medical Institute at Harvard Medical School which is rooted in psychoneuroendocrinology and focuses on relaxation techniques, exercise, cognitive restructuring, diet, and social support. In addition, naturopathic methods of selfregulation and self-care are incorporated.


Locations(1)

Robert-Bosch-Krankenhaus, Abteilung für Hämatologie, Onkologie und Palliativmedizin

Stuttgart, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03735992


Related Trials